STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

839

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Coronary Atherosclerosis
Interventions
DRUG

Rimonabant (SR141716)

DRUG

Placebo

Trial Locations (9)

44195

The Cleveland Clinic Foundation, Cleveland

Unknown

sanofi-aventis, Australia, Macquarie Park

sanofi-aventis, Belgium, Diegem

Sanofi-Aventis Administrative Office, Laval

sanofi-aventis, France, Paris

sanofi-aventis Italy, Milan

sanofi-aventis, Netherlands, Gouda

sanofi-aventis Poland, Warsaw

sanofi-aventis Spain, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY